Advertisement

NARI

Inari Medical, Inc.

Healthcare

Set alert

Price alert · NARI

All alert types
79.97 0.00 0.00%
As of Feb 18, 2025
79.96 Day range 79.97

52-week range unavailable

YTD
+56.65%
1 year
+41.87%
Open
79.96
Prev close
79.97
Mkt cap
4.68B
Vol
2.36M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
79.96
High
79.97
Forward P/E
571.21
Beta
1.03
Short ratio
0.54
Inst. own
95.56%
Dividend
0.00
Ex-div date
Earnings
Feb 28, 2024
50-d avg
70.53
200-d avg
53.51
1y target
78.03

2Y chart

Chart tools
Interval
NARI two-year price chart36.747.558.469.280.0Feb 23Jul 23Dec 23May 24Sep 24Feb 25

Key statistics

Market cap
4.68B
Enterprise value
4.60B
Trailing P/E
0.00
Forward P/E
571.21
PEG ratio
0.00
Price / sales
8.15
Price / book
10.75
EPS (TTM)
-1.35
Beta
1.03
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-13.68%
Revenue (TTM)
574.50M
Revenue growth
21.40%
Free cash flow
86.61M
Total cash
111.54M
Total debt
32.72M
Return on equity
-17.72%
Shares outstanding
58.56M
Short % of float
5.36%
50-day average
70.53
200-day average
53.51

Analyst view

Consensus: hold

Hold
Price target (mean) 78.03 -2.4% downside
Target (low)
68.20
Target (mean)
78.03
Target (high)
80.00
Ratings (0m) 7 1 buy · 6 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold6
  • Sell0
  • Strong sell0

Next earnings

Feb 28, 2024

Expected Feb 28, 2024. Consensus EPS estimate 0.00667.

Earnings history

Financials — quick view

All financials
NARI Revenue — quarterly 153.39M
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024
NARI Net income — quarterly -18.37M
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024
NARI EPS — quarterly -0.31
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024

Earnings

NARI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 28, 2024Dec 1, 20230.01———

Upgrades / downgrades

NARI analyst upgrades and downgrades
DateFirmActionFromTo
Jan 8, 2025BTIGdownBuyNeutral
Jan 7, 2025Wells FargodownOverweightEqual-Weight
Jan 7, 2025William BlairdownOutperformMarket Perform
Jan 7, 2025Piper SandlermainNeutralNeutral
Jan 7, 2025Canaccord GenuitydownBuyHold
Jan 7, 2025BairddownOutperformNeutral

About Inari Medical, Inc.

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. As of February 19, 2025, Inari Medical, Inc. operates as a subsidiary of Stryker Corporation.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on NARI — it syncs with the Stock Master app.

Insider holders

NARI insider holders
InsiderRelationLatest transactionDateShares held
CHAMBERS REBECCADirectorSaleJun 20, 20249,684
HILL MITCH CChief Financial OfficerSaleSep 11, 2024181,200
HOFFMAN WILLIAM HDirectorSaleJan 5, 2025238,987
HYKES ANDREW JChief Executive OfficerStock Award(Grant)Feb 18, 20250
LUCCHESE CYNTHIA LDirectorStock Award(Grant)Apr 23, 202438,429
ROOT JONATHAN DDirectorStock Award(Grant)Apr 23, 2024541,484

Institution ownership

NARI institution ownership
Holder% heldSharesValueReported
Blackrock Inc.14.33%8,389,788670.93MDec 30, 2024
Vanguard Group Inc9.61%5,628,875450.14MDec 30, 2024
Hcc Manager LLC 4.98%2,914,246233.05MDec 30, 2024
Morgan Stanley3.67%2,150,771172.00MDec 30, 2024
State Street Corporation3.56%2,083,195166.59MDec 30, 2024
Brown Advisory Inc.3.09%1,811,136144.84MDec 30, 2024

Fund ownership

NARI fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF5.54%3,243,299259.37MNov 29, 2024
Vanguard Total Stock Market Index Fund2.67%1,560,449124.79MSep 29, 2024
iShares Russell 2000 ETF2.54%1,486,744118.89MNov 29, 2024
Vanguard Small-Cap Index Fund2.12%1,241,52799.28MSep 29, 2024
American Century Small Cap Growth Fund1.43%834,35666.72MDec 30, 2024
Baron Discovery Fund1.31%766,95661.33MSep 29, 2024
Advertisement